Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $430 | $463 | $469 | $80 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $164 | $6,805 | $6,271 | $5,942 |
| Inventory | $485 | $476 | $433 | $454 |
| Other Curr. Assets | $1,062 | $0 | $0 | $0 |
| Total Curr. Assets | $2,140 | $7,745 | $7,172 | $6,475 |
| Property Plant & Equip (Net) | $196 | $98 | $107 | $119 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,312 | $0 | $0 | $0 |
| Total NC Assets | $6,509 | $98 | $107 | $119 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,649 | $7,843 | $7,279 | $6,594 |
| Liabilities | – | – | – | – |
| Payables | $589 | $595 | $11 | $14 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $959 | $874 | $866 | $782 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,930 | $1,119 | $1,445 | $1,443 |
| Total Curr. Liab. | $3,478 | $2,588 | $2,322 | $2,239 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $431 | $445 | $414 | $45 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $431 | $445 | $414 | $45 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,909 | $3,033 | $2,735 | $2,284 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | $2,528 | $2,609 | $2,565 | $2,438 |
| AOCI | $540 | $538 | $330 | $254 |
| Other Equity | $1,670 | $1,661 | $1,646 | $1,616 |
| Total Equity | $4,740 | $4,810 | $4,544 | $4,310 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,649 | $7,843 | $7,279 | $6,594 |
| Net Debt | -$430 | -$463 | -$469 | -$80 |